Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Enanta Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
26 Aug 2022 | Enanta Pharma to Raise up to USD100 Million in Public Offering of Shares | Equity Offering | - |
Enanta Pharmaceuticals Inc |
12 Mar 2021 | Enanta Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with PRA Health Sciences Inc for EDP-938 (GDCT0419470) | Contract Service Agreement |
Enanta Pharmaceuticals Inc
|
PRA Health Sciences Inc |
05 Nov 2020 | Enanta Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with PRA Health Sciences Inc for EDP-514 (GDCT0414770) | Contract Service Agreement |
Enanta Pharmaceuticals Inc
|
PRA Health Sciences Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer